Emmanouil S. Brilakis
Emmanouil S. Brilakis
Minneapolis Heart Institute and Minneapolis Heart Institute Foundation
Подтвержден адрес электронной почты в домене allina.com - Главная страница
Oxidized phospholipids, Lp (a) lipoprotein, and coronary artery disease
S Tsimikas, ES Brilakis, ER Miller, JP McConnell, RJ Lennon, ...
New England Journal of Medicine 353 (1), 46-57, 2005
Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American …
JE Tamis-Holland, H Jneid, HR Reynolds, S Agewall, ES Brilakis, ...
Circulation 139 (18), e891-e908, 2019
A percutaneous treatment algorithm for crossing coronary chronic total occlusions
ES Brilakis, JA Grantham, S Rinfret, RM Wyman, MN Burke, ...
JACC: Cardiovascular Interventions 5 (4), 367-379, 2012
Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for …
ID Moussa, LW Klein, B Shah, R Mehran, MJ Mack, ES Brilakis, JP Reilly, ...
Journal of the American college of cardiology 62 (17), 1563-1570, 2013
Lipoprotein-associated phospholipase A (2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies.
A Thompson, P Gao, L Orfei, S Watson, E Di Angelantonio, S Kaptoge, ...
Lancet (London, England) 375 (9725), 1536-1544, 2010
Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR (National Cardiovascular Data Registry)
ES Brilakis, S Banerjee, D Karmpaliotis, WL Lombardi, TT Tsai, KA Shunk, ...
JACC: Cardiovascular Interventions 8 (2), 245-253, 2015
Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease: a meta-analysis of 89,883 patients enrolled in randomized …
S Garcia, Y Sandoval, H Roukoz, S Adabag, M Canoniero, ...
Journal of the American College of Cardiology 62 (16), 1421-1431, 2013
Angiographic success and procedural complications in patients undergoing percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 18,061 …
VG Patel, KM Brayton, A Tamayo, O Mogabgab, TT Michael, N Lo, ...
JACC: Cardiovascular Interventions 6 (2), 128-136, 2013
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ...
The Lancet 391 (10117), 205-218, 2018
Plasma leptin and prognosis in patients with established coronary atherosclerosis
R Wolk, P Berger, RJ Lennon, ES Brilakis, BD Johnson, VK Somers
Journal of the American College of Cardiology 44 (9), 1819-1824, 2004
Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions: the PROGRESS CTO …
G Christopoulos, DE Kandzari, RW Yeh, FA Jaffer, D Karmpaliotis, ...
JACC: Cardiovascular Interventions 9 (1), 1-9, 2016
Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry
DJ Kumbhani, PG Steg, CP Cannon, KA Eagle, SC Smith Jr, S Goto, ...
European heart journal 35 (41), 2864-2872, 2014
Guiding principles for chronic total occlusion percutaneous coronary intervention: a global expert consensus document
ES Brilakis, K Mashayekhi, E Tsuchikane, N Abi Rafeh, K Alaswad, ...
Circulation 140 (5), 420-433, 2019
Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up
ES Brilakis, JP McConnell, RJ Lennon, AA Elesber, JG Meyer, PB Berger
European heart journal 26 (2), 137-144, 2005
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial
PJ Devereaux, E Duceppe, G Guyatt, V Tandon, R Rodseth, BM Biccard, ...
The Lancet 391 (10137), 2325-2334, 2018
Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events
S Tsimikas, ES Brilakis, RJ Lennon, ER Miller, JL Witztum, JP McConnell, ...
Journal of lipid research 48 (2), 425-433, 2007
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
JC Tardif, CM Ballantyne, P Barter, JL Dasseux, ZA Fayad, MC Guertin, ...
European heart journal 35 (46), 3277-3286, 2014
Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease
R Wolk, P Berger, RJ Lennon, ES Brilakis, VK Somers
Circulation 108 (18), 2206-2211, 2003
Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions
GE Christakopoulos, G Christopoulos, M Carlino, OM Jeroudi, M Roesle, ...
The American journal of cardiology 115 (10), 1367-1375, 2015
Prevalence and management of coronary chronic total occlusions in a tertiary Veterans Affairs hospital
OM Jeroudi, ME Alomar, TT Michael, AE Sabbagh, VG Patel, ...
Catheterization and Cardiovascular Interventions 84 (4), 637-643, 2014
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20